Wells Fargo
AXN

Wells Fargo’s Aoxing Pharmaceutical Company Inc. AXN Stock Holding History

Wells Fargo’s Portfolio AXN Stock Details AXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-125
Closed – – 6561
2014
Q3 		$0 Buy
+125
New +$40 ﹤0.01% 6478

Other funds holding AXN

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Wells Fargo's AXN Position: Q4 2014 in Review

Wells Fargo sold out of Aoxing Pharmaceutical Company Inc. (AXN) in Q4 2014, closing a stake of 125 shares.

Wells Fargo first reported a position in AXN in Q3 2014 and held it in 1 quarter. The position peaked at $0 in Q3 2014. 3 funds tracked by Wall St. Rank hold AXN as of Q4 2014.

  • Wells Fargo reported no remaining Aoxing Pharmaceutical Company Inc. position as of Q4 2014 after selling out during the quarter.
  • Wells Fargo sold 125 Aoxing Pharmaceutical Company Inc. shares in Q4 2014.
  • Wells Fargo first reported a position in Aoxing Pharmaceutical Company Inc. in Q3 2014 and held it in 1 quarter.
  • Wells Fargo's Aoxing Pharmaceutical Company Inc. position peaked at $0 in Q3 2014.
  • 3 funds tracked by Wall St. Rank held Aoxing Pharmaceutical Company Inc. as of Q4 2014.

Based on Wells Fargo's 13F filing for Q4 2014, filed 11 Feb 2015.